Automated nucleic acid extraction from MRSA and GBS
Optimized Pathogen Detection: A Compatibility Evaluation of Revvity chemagic™ 360 system and NZYTech qPCR Kits for MRSA and GBS detection
Automated nucleic acid extraction systems are essential in molecular diagnostic labs for efficient, reliable, and timely results. They reduce hands-on time, ensure consistency, and enable high-throughput processing of multiple samples simultaneously. Group B Streptococcus (GBS) and Methicillin-resistant Staphylococcus aureus (MRSA) are significant bacterial pathogens linked to healthcare-associated infections (HAIs) in vulnerable populations such as newborns, pregnant women, and hospitalized patients. Swift and precise detection of these pathogens is crucial for effective treatment and the prevention of HAIs, underscoring the importance of robust diagnostic methods in healthcare settings.
Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability.
Please note that product labelling (such as kit insert, product label, and kit box) may be different compared to the company branding. Please contact your local representative for further details.